Last updated: March 18, 2024
Sponsor: Kasr El Aini Hospital
Overall Status: Active - Recruiting
Phase
2
Condition
N/ATreatment
Ultrasound- guided Fascia Transversalis plane block
Fentanyl
Ultrasound-guided Transversus abdominus plane block
Clinical Study ID
NCT06326944
MS-527-2023
Ages 1-6 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ASA physical status I-II
Exclusion
Exclusion Criteria:
- Parents' refusal to participate in the study.
- Coagulopathy (i.e. Platelets ≤ 50,000 and/or INR> 1.5).
- Localized infection at the site of needle insertion.
- Known hypersensitivity or allergies to any of the used drugs.
Study Design
Total Participants: 50
Treatment Group(s): 5
Primary Treatment: Ultrasound- guided Fascia Transversalis plane block
Phase: 2
Study Start date:
January 18, 2024
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
Cairo University Hospitals
Giza, 11562
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.